The present disclosure describes endoluminal devices, such as stents and stent grafts capable of being bent smoothly, with various benefits resulting therefrom.

The present disclosure describes endoluminal devices, such as stents and stent grafts capable of being bent smoothly, with various benefits resulting therefrom.

An aortic arch graft includes a generally cylindrical member formed from a plurality of struts having a proximal end and a distal end and a longitudinally extending lumen. The proximal end is configured for deployment within the ascending aorta and the distal end configured for deployment in the descending thoracic aorta. The aortic arch graft includes a graft material having an opening disposed between the proximal end and distal end with a plurality of radiopaque markers disposed around a periphery of the opening. The opening within the graft material allows blood flow transverse to the longitudinal lumen of the generally cylindrical member.

Biodegradable magnesium alloy implantable medical devices are protected to delay onset of corrosion, and thus biodegradability, or to corrode more uniformly. The protection allows for extended effective use of the devices while maintaining biodegradability. Examples of protective coatings include conversion coatings that at least partially remove exposed second phases from a surface of the magnesium alloy and coatings that provide a barrier between water and the surface of the magnesium alloy.

Biodegradable magnesium alloy implantable medical devices are protected to delay onset of corrosion, and thus biodegradability, or to corrode more uniformly. The protection allows for extended effective use of the devices while maintaining biodegradability. Examples of protective coatings include conversion coatings that at least partially remove exposed second phases from a surface of the magnesium alloy and coatings that provide a barrier between water and the surface of the magnesium alloy.

A covered stent (100) includes a first wave ring (20) provided on at least one end of the covered stent (100), wherein the first wave ring (20) is formed of braided wires by means of braiding; each of the braided wires has wire heads (21) and a wire rod (22), with the wire heads (21) being located at two ends of the wire rod (22); and the wire heads (21) of the braided wire are wound around the adjacent wire rod (22); and the covered stent (100) further includes a limiting unit (40), with the limiting unit (40) being arranged on the wire head (21) and the wire rod (22) adjacent to the wire head (21), and the limiting unit (40) limiting the range of axial and/or radial movement of the wire head (21) relative to the wire rod (22).

A covered stent (100) includes a first wave ring (20) provided on at least one end of the covered stent (100), wherein the first wave ring (20) is formed of braided wires by means of braiding; each of the braided wires has wire heads (21) and a wire rod (22), with the wire heads (21) being located at two ends of the wire rod (22); and the wire heads (21) of the braided wire are wound around the adjacent wire rod (22); and the covered stent (100) further includes a limiting unit (40), with the limiting unit (40) being arranged on the wire head (21) and the wire rod (22) adjacent to the wire head (21), and the limiting unit (40) limiting the range of axial and/or radial movement of the wire head (21) relative to the wire rod (22).

A medical implant (20) includes first and second ring members (22, 24), each including a resilient framework (26) having a generally cylindrical form. A tubular sleeve (28) is fixed to the first and second ring members so as to hold the ring members in mutual longitudinal alignment, thereby defining a lumen (32) passing through the ring members. A constricting element (30) is fit around the sleeve at a location intermediate the first and second ring members so as to reduce a diameter of the lumen at the location.

A medical implant (20) includes first and second ring members (22, 24), each including a resilient framework (26) having a generally cylindrical form. A tubular sleeve (28) is fixed to the first and second ring members so as to hold the ring members in mutual longitudinal alignment, thereby defining a lumen (32) passing through the ring members. A constricting element (30) is fit around the sleeve at a location intermediate the first and second ring members so as to reduce a diameter of the lumen at the location.

Biodegradable magnesium alloy implantable medical devices are protected to delay onset of corrosion, and thus biodegradability, or to corrode more uniformly. The protection allows for extended effective use of the devices while maintaining biodegradability. Examples of protective coatings include conversion coatings that at least partially remove exposed second phases from a surface of the magnesium alloy and coatings that provide a barrier between water and the surface of the magnesium alloy.